News | May 04, 2022
Pfizer sets up global drug development centre in Chennai
The facility is among 12 centres established worldwide, and the first in Asia
The facility is among 12 centres established worldwide, and the first in Asia
Highlighted as game changer in drug development & delivery special feature on innovative technologies for improving drug solubility and bioavailability
Through this consortium, Lonza will collaborate with other industry leaders to advance the research and development of inhalation technologies
The collaboration will utilize Avatar-Rx, LifeMine’s proprietary genomically-enabled drug discovery platform to access evolutionarily derived lead small molecules
Under the agreement, Lonza will deliver cGMP-standard drug substance for clinical supply
The expansion is part of Lonza’s continued investment in its global manufacturing network, aiming to build a comprehensive offering for global customers
N Yuvraj, Joint Secretary, Dept of Pharmaceuticals, Satish Reddy, Chairman, Dr Reddy’s Laboratories; Kiran Mazumdar Shaw, Executive Chairperson, Biocon Group; Sanjiv Navangul, MD & CEO, Bharat Serums and Vaccines and Shravil Patel, MD, Zydus Lifesciences discuss the way forward for the India pharma industry
Robust pipeline with around 50 projects in clinical development / cardiology portfolio poised for growth with launch products Kerendia (finerenone) and Verquvo (vericiguat)
The researchers are of the view that the new drug designing strategy demonstrated by them could also be adopted to treat retroviral infections.
AMX0035 is an investigational therapy for the treatment of amyotrophic lateral sclerosis (ALS).
Subscribe To Our Newsletter & Stay Updated
